Two cases of Cushing's syndrome due to overuse of topical steroid in the diaper area

Pediatric Dermatology

Volumn 25, Issue 5, 2008, Pages 544-547

  Semiz, Serap ^a,b   Balci, Yasemin Işik ^a   Ergin, Şeniz ^a   Candemir, Maşallah ^a   Polat, Aziz ^a  

^a PAMUKKALE UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CLOBETASOL PROPIONATE; CORTICOSTEROID; CORTICOTROPIN; HYDROCORTISONE;

ARTICLE; CASE REPORT; CAUSE OF DEATH; CORTICOTROPIN TEST; CUSHING SYNDROME; CYTOMEGALOVIRUS INFECTION; DERMATITIS; DIAPER DERMATITIS; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG MISUSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HUMAN; HYPERTRICHOSIS; INFANT; OBESITY; PRIORITY JOURNAL; SKIN ATROPHY; SKIN CANDIDIASIS; WEIGHT GAIN;

ADMINISTRATION, TOPICAL; CANDIDIASIS, CUTANEOUS; CLOBETASOL; CUSHING SYNDROME; CYTOMEGALOVIRUS INFECTIONS; DIAPER RASH; FATAL OUTCOME; FEMALE; GLUCOCORTICOIDS; HUMANS; INFANT;

EID: 53749106646     PISSN: 07368046     EISSN: 15251470     Source Type: Journal    
DOI: 10.1111/j.1525-1470.2008.00735.x     Document Type: Article

References (13)

1. Hengge UR, Ruziska T, Shwartz RA et al. Adverse effects of topical glucocorticosteroids. J Am Acad Dermatol 2006 54 : 1 15.
2. Wolkerstorfer A, Visser RL, De Waard van der Spek FB et al. Efficacy and safety of wet-wrap dressings in children with severe atopic dermatitis: influence of cortico-steroid dilution. Br J Dermatol 2000 143 : 999 1004.
3. Keipert JA, Kelly R. Temporary Cushing's syndrome from percutaneous absorption of betamethasone 17-valerate. Med J Aust 1971 1 : 542 544.
4. Carruthers JA, August PJ, Staughton RC. Observations on the systemic effect of topical clobetasol propionate (Dermovate). Br Med J 1975 4 : 203 204.
5. Şiklar Z, Bostanci I, Atli Ö et al. An infantile Cushing syndrome due to misuse of topical steroid. Pediatr Dermatol 2004 21 : 561 563.
6. Gilbertson EO, Spellman MC, Piacquadio DJ et al. Super potent topical corticosteroid use associated with adrenal suppression: clinical considerations. J Am Acad Dermatol 1998 38 : 318 321.
7. Park YJ, Park KS, Kim JH et al. Reproducibility of the cortisol response to stimulation with the low dose (1 microg) of ACTH. Clin Endocrinol 1999 51 : 153 158.
8. Quddusi S, Browne P, Toivola B et al. Cushing syndrome due to surreptitious glucocorticoid administration. Arch Intern Med 1998 158 : 294 296.
9. Pan J, Ju D, Wang Q et al. Dexamethasone inhibits the antigen presentation of dendritic cells in MHC class II pathway. Immunol Lett 2001 76 : 153 161.
10. Boumpas DT, Paliogianni F, Anastassiou ED et al. Glucocorticosteroid action on the immune system: molecular and cellular aspects. Clin Exp Rheumatol 1991 9 : 413 423.
11. Güven A, Karadeniz S, Aydin O et al. Fatal disseminated cytomegalovirus infection in an infant with Cushing's syndrome caused by topical steroid. Horm Res 2005 64 : 35 38.
12. Weaver J. Post marketing safety review - PID D010141. Drugs: topical corticosteroids. FDA Web site. 9 July 2001. http://www.fda.gov/ohrms/dockets/ac/ 03/briefing/3999B1_21_Weaver-Memo%2007-09-01.pdf [accessed on 2 September 2008].
13. Clotrimazole, USP and betamethasone dipropionate, USP. Document information page. FDA Web site. 3 October 2003. http://www.fda.gov/cder/foi/ label/2003/20010slr005_lotrisone_lbl.pdf [accessed on 2 September 2008].